Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes

被引:50
作者
Heidari, Firouzeh [1 ]
Rabizadeh, Soghra [1 ]
Mansournia, Mohammad Ali [2 ]
Mirmiranpoor, Hossein [1 ]
Salehi, Salome Sadat [1 ]
Akhavan, Setare [3 ]
Esteghamati, Alireza [1 ]
Naldijavani, Manouchehr [1 ]
机构
[1] Univ Tehran Med Sci, Vali Asr Hosp, EMRC, POB 13145-784, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[3] Univ Tehran Med Sci, Vali Asr Hosp, Gynecol Ward, Tehran, Iran
关键词
Endometrial carcinoma; Type2; diabetes; Inflammatory markers; Oxidative stress markers; Antioxidant marker; GLYCATION END-PRODUCTS; CANCER-RISK; INTERLEUKIN-6; HORMONE;
D O I
10.1016/j.cyto.2019.05.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background. The role of chronic inflammation and oxidative stress in the development of diabetes and cancer has been established. In this study, we aimed to investigate inflammatory and oxidative stress markers in patients with diabetes (DM) and endometrial carcinoma (EC) separately and in combination. Methods: In a case-control study design, a total of 88 participants were enrolled including: 37 patients with EC (19 with DM and 18 without DM), 29 with type2 diabetes and 22 healthy controls. Cancer patients were sampled before treatment. Serum oxidative stress markers including: oxidized low density lipoprotein (ox-LDL,) nitric oxide (NO), advanced glycation end-products (AGEs) and advanced oxidation protein products (AOPP), malondialdehyde (MDA); ferric reducing ability of plasma (FRAP), as an antioxidant marker, and inflammatory markers including: Interleukin 6 (IL6), C reactive protein (CRP) and tumor necrosis factor alpha (TNF alpha) were measured. Results: Ox-LDL, NO, MDA, AOPP and AGE were increased in all patients either with endometrial carcinoma and/or diabetes compared to healthy controls (p < 0.05). Patients with both EC and DM had higher oxidative markers including: OX-LDL (17.47 +/- 0.84 vs. 12.36 +/- 0.91), NO (82.27 +/- 5.75 vs. 76.34 +/- 5.36), MDA (3.3 +/- 0.1 vs. 2.75 +/- 0.48) and AGE (73.89 +/- 5.71 vs. 69.02 +/- 3.14) compared to those with EC alone (rho < 0.05). Levels of FRAP was lower in patients with both diabetes and cancer, cancer alone and diabetes alone compared to healthy controls (p < 0.05). Inflammatory markers, TNF alpha, IL6 and hs-CRP, were also significantly increased in patients with EC with and without DM compared to controls (rho < 0.05). However, there were no significant differences between two groups of EC regarding to inflammatory markers (rho > 0.05). Patients with DM had significantly higher levels of inflammatory markers compared to control group (all rho < 0.05). In addition, significant subadditive interaction effect between EC and DM regarding levels of oxLDL, NO, AGE, AOPP and FRAP) was observed (p < 0.05). Conclusion: Increased levels of chronic inflammatory and oxidative stress markers were observed in both endometrial carcinoma and diabetes. Additional effect of diabetes in patients with cancer was mediated more significantly via increase in oxidative stress rather than inflammatory markers.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 33 条
  • [1] High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer
    Bellone, S
    Watts, K
    Cane, S
    Palmieri, M
    Cannon, MJ
    Burnett, A
    Roman, JJ
    Pecorelli, S
    Santin, AD
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 98 (01) : 92 - 98
  • [2] The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay
    Benzie, IFF
    Strain, JJ
    [J]. ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) : 70 - 76
  • [3] Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort-A Factor Analysis
    Dossus, Laure
    Lukanova, Annekatrin
    Rinaldi, Sabina
    Allen, Naomi
    Cust, Anne E.
    Becker, Susen
    Tjonneland, Anne
    Hansen, Louise
    Overvad, Kim
    Chabbert-Buffet, Nathalie
    Mesrine, Sylvie
    Clavel-Chapelon, Francoise
    Teucher, Birgit
    Chang-Claude, Jenny
    Boeing, Heiner
    Drogan, Dagmar
    Trichopoulou, Antonia
    Benetou, Vasiliki
    Bamia, Christina
    Palli, Domenico
    Agnoli, Claudia
    Galasso, Rocco
    Tumino, Rosario
    Sacerdote, Carlotta
    Bueno-de-Mesquita, H. Bas
    van Duijnhoven, Fraenzel J. B.
    Peeters, Petra H. M.
    Onland-Moret, N. Charlotte
    Redondo, Maria-Luisa
    Travier, Noemie
    Sanchez, Maria-Jose
    Altzibar, Jone M.
    Chirlaque, Maria-Dolores
    Barricarte, Aurelio
    Lundin, Eva
    Khaw, Kay-Tee
    Wareham, Nicholas
    Fedirko, Veronika
    Romieu, Isabelle
    Romaguera, Dora
    Norat, Teresa
    Riboli, Elio
    Kaaks, Rudolf
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 (08) : 787 - 799
  • [4] Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: the EPIC study
    Dossus, Laure
    Becker, Susen
    Rinaldi, Sabina
    Lukanova, Annekatrin
    Tjonneland, Anne
    Olsen, Anja
    Overvad, Kim
    Chabbert-Buffet, Nathalie
    Boutron-Ruault, Marie-Christine
    Clavel-Chapelon, Francoise
    Teucher, Birgit
    Chang-Claude, Jenny
    Pischon, Tobias
    Boeing, Heiner
    Trichopoulou, Antonia
    Benetou, Vasiliki
    Valanou, Elisavet
    Palli, Domenico
    Sieri, Sabina
    Tumino, Rosario
    Sacerdote, Carlotta
    Galasso, Rocco
    Redondo, Maria-Luisa
    Bonet Bonet, Catalina
    Molina-Montes, Esther
    Altzibar, Jone M.
    Chirlaque, Maria-Dolores
    Ardanaz, Eva
    Bueno-de-Mesquita, H. Bas
    van Duijnhoven, Franzel J. B.
    Peeters, Petra H. M.
    Onland-Moret, N. Charlotte
    Lundin, Eva
    Idahl, Annika
    Khaw, Kay-Tee
    Wareham, Nicholas
    Allen, Naomi
    Romieu, Isabelle
    Fedirko, Veronika
    Hainaut, Pierre
    Romaguera, Dora
    Norat, Teresa
    Riboli, Elio
    Kaaks, Rudolf
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (08) : 2032 - 2037
  • [5] Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial
    Esteghamati, Alireza
    Eskandari, Delaram
    Mirmiranpour, Hossein
    Noshad, Sina
    Mousavizadeh, Mostafa
    Hedayati, Mehdi
    Nakhjavani, Manouchehr
    [J]. CLINICAL NUTRITION, 2013, 32 (02) : 179 - 185
  • [6] Chronic inflammation and oxidative stress in human carcinogenesis
    Federico, Alessandro
    Morgillo, Floriana
    Tuccillo, Concetta
    Ciardiello, Fortunato
    Loguercio, Carmela
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (11) : 2381 - 2386
  • [7] Case-control study of inflammatory markers and the risk of endometrial cancer
    Friedenreich, Christine M.
    Langley, Annie R.
    Speidel, Thomas P.
    Lau, David C. W.
    Courneya, Kerry S.
    Csizmadi, Ilona
    Magliocco, Anthony M.
    Yasui, Yutaka
    Cook, Linda S.
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2013, 22 (04) : 374 - 379
  • [8] Harada K, 2004, IN VIVO, V18, P449
  • [9] The contribution of endogenous sources of DNA damage to the multiple mutations in cancer
    Jackson, AL
    Loeb, LA
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 477 (1-2) : 7 - 21
  • [10] Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus
    Kalousová, M
    Skrha, J
    Zima, T
    [J]. PHYSIOLOGICAL RESEARCH, 2002, 51 (06) : 597 - 604